Clinical Trial Update: Causes and Prevention of Thromboembolic Disease in Nephrotic Syndrome [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial from the University of Aarhus explored the causes and prevention of thromboembolic disease in nephrotic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotic Syndrome
• Thromboembolic Disease

Snippet

Sponsor: University of Aarhus | Conditions: Nephrotic Syndrome, Thromboembolic Disease | Phase 1, Phase 2 | Status: COMPLETED